Thesis
NVO is transitioning from a completed Cycle Wave 2 into a new multi-year expansion phase. The long-term bull structure remains intact, with fundamentals now acting as a catalyst for the next cycle leg.
Context
- Weekly timeframe
- Primary bull trend originates from the 2009 GFC low (< $1)
- Cycle Wave 1 completed in July 2024
- Deep corrective Cycle Wave 2 now appears complete
What I see
-Structural reversal underway from long-term trend support
- Price stabilizing in a major accumulation / buy zone
- New Wegovy pill acts as a fundamental trigger aligning with the technical reversal
- Momentum and structure support the start of Cycle Wave 3
What matters now
- Holding the current base keeps the Cycle Wave 3 thesis intact
- This phase is about accumulation, not timing short-term moves
Buy / Accumulation zone
- Current zone remains suitable for long-term positioning
- This is where multi-year risk/reward is defined
Targets
- Cycle Wave 3 (1.618 Fib): ~$273. Expected around early 2029. Approx. +450% from the buy area
- Cycle Wave 5: ~$415. Expected around 2033. Approx. +730% from the buy area
Income
- Dividend yield ~2.1% adds meaningful carry while holding
Conclusion
Strong technical cycle alignment + improving fundamentals make
NVO a compelling long-term hold. This is a position built to be held through volatility, not traded.
Context
- Weekly timeframe
- Primary bull trend originates from the 2009 GFC low (< $1)
- Cycle Wave 1 completed in July 2024
- Deep corrective Cycle Wave 2 now appears complete
What I see
-Structural reversal underway from long-term trend support
- Price stabilizing in a major accumulation / buy zone
- New Wegovy pill acts as a fundamental trigger aligning with the technical reversal
- Momentum and structure support the start of Cycle Wave 3
What matters now
- Holding the current base keeps the Cycle Wave 3 thesis intact
- This phase is about accumulation, not timing short-term moves
Buy / Accumulation zone
- Current zone remains suitable for long-term positioning
- This is where multi-year risk/reward is defined
Targets
- Cycle Wave 3 (1.618 Fib): ~$273. Expected around early 2029. Approx. +450% from the buy area
- Cycle Wave 5: ~$415. Expected around 2033. Approx. +730% from the buy area
Income
- Dividend yield ~2.1% adds meaningful carry while holding
Conclusion
Strong technical cycle alignment + improving fundamentals make
免責聲明
這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
